Changes in the BDNF/proBDNF ratio have been measured in the peripheral blood and cerebrospinal fluid of both animal models and human patients with Alzheimer’s, Parkinson’s, and Huntington’s disease. This evidence concerns the gene BDNF and Parkinson disease.